U.S., Feb. 4 -- An application to own the trademark for 'PR' has been filed on Mar. 18, 2024.
Owner(s):
PharmaGend Global Medical Services Pte Ltd; 3 TUAS SOUTH AVENUE 4, SINGAPORE 637610, SINGAPORE
Goods and/or Services:
For: Immunological products for intravenous injections, namely for immune system support, such as vaccines, monoclonal antibodies (mAbs), Cytokines/Cytokine Inhibitors; tablets for medicines, specifically diuretic, anti-fungal, digestive disorders, anti-inflammatory, antidiabetic, dementia tablets for treating common infections and chronic diseases; drinking water fused with electrolytes, salts, hemodialysis solution, suitable for rehydration and maintenance therapy for medical purposes; gelatin capsules sold empty for...